| ₹ crore | Q1 FY27 | Q1 FY26 | Change |
|---|---|---|---|
| Revenue | 81.4 | 70.9 | +14.8% |
| EBITDA | 28.1 | 29.5 | −4.6% |
| EBITDA margin | 34.6% | 41.6% | −7.1 pts |
| Profit before tax | 8.3 | 12.2 | −31.6% |
| Net profit | 5.3 | 7.0 | −24.3% |
| EPS | ₹1.26 | ₹1.75 | −28.0% |
Amounts on the left scale in ₹ crore; per cent on the right, dashed. L = lakh crore, K = thousand crore. Touch the chart to read any period.
| Tap a line for its trend | Currentlast 12M | FY26Mar 2026 | FY25Mar 2025 | FY24Mar 2024 | FY23Mar 2023 | FY22 and earlierAlpha Plus |
|---|
| 789 | — | — | — | — | FY22 and earlierEvery year the company has filed comes with Alpha Plus. | |
| 9.2 | 9.2 | 3.3 | 23.3 | 63.7 | ||
| 1.9 | 1.9 | 1.5 | 1.6 | 2.1 | ||
| 160 | 160 | 110 | 51.9 | 32.4 | ||
| 942 | — | — | — | — | ||
| 338 | 328 | 311 | 198 | 181 | ||
| — | +5.4% | +56.9% | +9.4% | — | ||
| 108 | 109 | 142 | 80.5 | 58.4 | ||
| 31.9% | 33.4% | 45.7% | 40.6% | 32.2% | ||
| 40.0 | 44.4 | 87.1 | 36.1 | 21.2 | ||
| 31.1 | 32.8 | 56.1 | 21.6 | 14.9 | ||
| 9.2% | 10.0% | 18.0% | 10.9% | 8.2% | ||
| ₹7.37 | ₹7.80 | ₹13.45 | ₹5.28 | ₹4.57 | ||
| — | −42.1% | +154.7% | +15.7% | — | ||
| — | 15.8 | −52.9 | 19.1 | −35.2 | ||
| — | −37.0 | −14.5 | −42.9 | −53.2 | ||
| −21.2 | −21.2 | −67.3 | −23.8 | −88.4 | ||
From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.
In ₹ Crore except Per Share 12 Months Ending | FY23 31/03/2023 | FY24 31/03/2024 | FY25 31/03/2025 | FY26 31/03/2026 | Current/LTM TTM · last close | |
|---|---|---|---|---|---|---|
| Market Capitalization | — | — | — | — | 789.4 | |
| - Cash, Equiv & ST Investments | 63.7 | 23.3 | 3.3 | 9.2 | 9.2 | |
| + Minority Interest | 2.1 | 1.6 | 1.5 | 1.9 | 1.9 | |
| + Total Debt | 32.4 | 51.9 | 109.8 | 160.2 | 160.2 | |
| Enterprise Value | — | — | — | — | 942.3 | |
| Revenue | 181.1 | 198.2 | 311.0 | 327.8 | 338.3 | |
| Growth %, YoY | — | +9.4 | +56.9 | +5.4 | — | |
| EBITDA | 58.4 | 80.5 | 142.1 | 109.3 | 108.0 | |
| Margin % | 32.23 | 40.63 | 45.70 | 33.36 | 31.92 | |
| EBIT | 21.2 | 36.1 | 87.1 | 44.4 | 40.0 | |
| Net Income | 14.9 | 21.6 | 56.1 | 32.8 | 31.1 | |
| Margin % | 8.24 | 10.90 | 18.04 | 10.01 | 9.19 | |
| EPS, Adj (current shares) | 4.57 | 5.28 | 13.45 | 7.80 | 7.37 | |
| Growth %, YoY | — | +15.7 | +154.7 | -42.1 | — | |
| Cash from Operations | -35.2 | 19.1 | -52.9 | 15.8 | — | |
| Capital Expenditures | -53.2 | -42.9 | -14.5 | -37.0 | — | |
| Free Cash Flow | -88.4 | -23.8 | -67.3 | -21.2 | -21.2 | |
Prices at the 29 October 2026 close · figures from the company's filings with NSE
Genesys International Corporation (NSE: GENESYS) had a market capitalisation of ₹715 crore at the 29 October 2026 close (₹171.15 a share), a PE ratio of 23.2 on the last four quarters' profit and a price-to-book ratio of 1.02. In FY26 its consolidated net profit was ₹32.6 crore on revenue of ₹328 crore; in Q1 FY27 (April–June 2026) it was ₹5.3 crore, down 25.1% year on year. Its debt-to-equity ratio was 0.23 on 31 March 2026. Promoters held 32.73% of the shares on 30 September 2026.
Genesys International Corporation's PE ratio is 23.2 at the 29 October 2026 close (₹171.15 a share): a market capitalisation of ₹715 crore divided by consolidated net profit of ₹30.8 crore over the last four quarters (Q2 FY26 to Q1 FY27). On FY26 net profit (₹32.6 crore) it is 22.0.
Genesys International Corporation's price-to-book (PB) ratio is 1.02 at the 29 October 2026 close: a market capitalisation of ₹715 crore divided by shareholders' equity (book value) of ₹704 crore on 31 March 2026. That is a book value of ₹168.35 per share against a share price of ₹171.15.
Genesys International Corporation's net worth — shareholders' equity in its consolidated balance sheet — was ₹704 crore on 31 March 2026, up 26.6% from ₹556 crore a year earlier. Its market value is a different figure: a market capitalisation of ₹715 crore at the 29 October 2026 close.
Genesys International Corporation's market capitalisation was ₹715 crore at the 29 October 2026 close: 4.18 crore shares at ₹171.15 each.
Genesys International Corporation's debt-to-equity ratio was 0.23 on 31 March 2026: borrowings of ₹160 crore against total equity of ₹705 crore. A year earlier, on 31 March 2025, it was 0.20.
Genesys International Corporation's basic earnings per share (EPS) were ₹7.91 in FY26, against ₹14.14 in FY25. Over the last four quarters (Q2 FY26 to Q1 FY27) they add up to ₹7.44.
No. Genesys International Corporation had borrowings of ₹160 crore on 31 March 2026 (consolidated balance sheet), a debt-to-equity ratio of 0.23. Its cash and current investments were ₹104 crore, so its net debt was ₹56.3 crore.
Genesys International Corporation's book value per share was ₹168.35 on 31 March 2026: shareholders' equity of ₹704 crore divided by the 4.18 crore shares in issue, up 20.6% from ₹139.57 a year earlier. The share price at the 29 October 2026 close was ₹171.15.
Promoters held 32.73% of Genesys International Corporation on 30 September 2026, up 1.23 percentage points from 31.50% the previous quarter and up 1.17 percentage points from 31.56% a year earlier, according to the shareholding pattern filed with NSE.
In FY26, Genesys International Corporation's return on equity (ROE) was 5.2% and its return on capital employed (ROCE) was 6.7%. ROE is net profit divided by average shareholders' equity (the start and end of the year); ROCE is operating profit (EBIT) divided by average capital employed (total assets less current liabilities). In FY25, ROE was 10.8% and ROCE 15.6%.
On 30 September 2026, Genesys International Corporation's shares were held by promoters 32.73%, foreign portfolio investors (FII/FPI) 1.68%, domestic institutions (DII) 0.81% (including mutual funds at 0.00%) and retail and other non-institutional investors 64.78%. Over the year, FII holding was down 3.01 percentage points from 4.69% and DII holding was down 0.66 percentage points from 1.47%.
At the 29 October 2026 closing prices, on FY26 net profit, Genesys International Corporation's PE ratio is 22.0, the second highest of the four: Excelsoft Technologies 20.7, Kellton Tech Solutions 6.3 and Orient Technologies 180.8, a peer average of 69.3. Each is the company's market capitalisation at that price divided by its FY26 net profit.
In FY26, Genesys International Corporation generated ₹15.8 crore of cash from operations and spent ₹37 crore on capital expenditure (property, plant, equipment and intangibles), leaving free cash flow of −₹21.2 crore. In FY25 it was −₹67.3 crore.
Genesys International Corporation's latest results are for Q1 FY27 (April–June 2026), filed on 14 August 2026: consolidated net profit ₹5.3 crore, down 25.1% from ₹7.1 crore in Q1 FY26; revenue from operations ₹81.4 crore, up 14.8% year on year.
In FY26 (April 2025–March 2026), Genesys International Corporation's consolidated net profit was ₹32.6 crore, down 42.1% from ₹56.2 crore in FY25, on revenue from operations of ₹328 crore (up 5.4%). Over three years, from FY23, net profit was up 70.8%.
Genesys International Corporation has not yet announced the date of its Q2 FY27 results (July–September 2026); under SEBI's listing rules (Regulation 33) they are due by 14 November 2026.
On FY26 consolidated figures, against Excelsoft Technologies, Kellton Tech Solutions and Orient Technologies: Genesys International Corporation's operating margin of 13.5% is the second highest of the four (Excelsoft Technologies 18.0%, Kellton Tech Solutions 9.9%, Orient Technologies 3.4%; peer average 10.4%); its return on equity of 5.2% is the third highest of the four (Excelsoft Technologies 7.5%, Kellton Tech Solutions 13.7%, Orient Technologies 1.4%; peer average 7.5%).
In FY26, Genesys International Corporation earned net profit of ₹32.6 crore on revenue of ₹328 crore, against ₹43.4 crore on ₹273 crore for Excelsoft Technologies. Genesys International Corporation's operating margin was 13.5% (Excelsoft Technologies 18.0%) and its return on equity 5.2% (Excelsoft Technologies 7.5%). At the 29 October 2026 close, Genesys International Corporation's market capitalisation was ₹715 crore against ₹898 crore for Excelsoft Technologies, and its PE ratio on FY26 profit 22.0 against 20.7.
From Genesys International Corporation's own consolidated results, balance sheets and shareholding patterns filed with NSE, and NSE prices (the latest used here: the 29 October 2026 close). Ratios are calculated by Alphave from those filings as each answer describes.
Consolidated figures from the company's filings with NSE; prices are NSE closing prices.